Potential applications of catestatin in cardiovascular diseases-Reference-Cited by-同舟云学术

Potential applications of catestatin in cardiovascular diseases

Published:2016-08 Issue:8 Volume:10 Page:877-888
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Zhao Yilin¹²,Zhu Dan¹

Affiliation:

1. Department of Cardiology, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology & Regulatory Peptides, Ministry of Health & Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 100191, China

2. The Departments of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA

Abstract

Catestatin (CST) was first named in 1997 for its catecholamine-inhibitory activity. It was discovered as a potent inhibitor of catecholamine secretion and as a regulator of histamine release. Accumulating evidence shows that CST is involved with cardiovascular diseases; however, whether CST is a protective factor for these conditions and the mechanisms by which such actions may be mediated are not well understood. In this article, we review recent basic research and clinical trials in the study of CST and summarize the association of CST with cardiovascular diseases. We review data obtained from MedLine via PubMed and from our own investigations.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Link

https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0086

Reference61 articles.

1. Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation

2. SECRETION FROM THE ADRENAL MEDULLA: BIOCHEMICAL EVIDENCE FOR EXOCYTOSIS

3. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

4. Inhibition of Insulin Secretion by Betagranin, an N-terminal Chromogranin A Fragment

5. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrophysiological Mechanism of Catestatin Antiarrhythmia: Enhancement of I _to , I _K, and I _K1 and Inhibition of I _Ca _‐L in Rat Ventricular Myocytes;Journal of the American Heart Association;2024-08-20

2. Catestatin in diagnosing cardiovascular and metabolic disorders in patients with comorbid hypertension;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2023-07-18

3. Prognostic Value of Plasma Catestatin Concentration in Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up;Journal of Clinical Medicine;2023-06-22

4. Role of Catestatin in the Cardiovascular System and Metabolic Disorders;Frontiers in Cardiovascular Medicine;2022-05-19

5. Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction;World Journal of Emergency Medicine;2022